Leopiras, Kathleen .
HRN: 20-08-19 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/03/2026
CO-AMOXICLAV 457MG/5ML, 70ML SUSPENSION (BOT)
01/03/2026
01/09/2026
ORAL
3ml
Q12
UTI
Checking Final Appropriateness